[Clinical significance of various metabolic disorders in patients with chronic pancreatitis].
The degree of hyperlipidemia, hyperthyrosinemia, hyperserotoninemia and enhanced release of bradykinin from kininogen in patients with chronic recurrent pancreatitis was found to be decreased upon the attainment of a clinical remission. In patients with more considerable and more stable metabolic disorders, the incidence of exacerbations and the rate of progression of pancreatic, enzyme-secretory deficiency appeared, according to the data of a 8-year follow up, greater than in those with lesser degree and resistance of metabolic shifts.
D002908:Chronic Disease; D005230:Fatty Acids, Nonesterified / Q000097:blood; D006801:Humans; D006949:Hyperlipidemias / Q000209:etiology; D010195:Pancreatitis / Q000378:metabolism*; D012008:Recurrence; D012701:Serotonin / Q000097:blood; D014280:Triglycerides / Q000097:blood; D014443:Tyrosine / Q000097:blood
D005230:Fatty Acids, Nonesterified; D014280:Triglycerides; D012701:Serotonin; D014443:Tyrosine
Klinicheskoe znachenie nekotorykh metabolicheskikh narusheniĭ u bol'nykh khronicheskim pankreatitom.